Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Treatment choices : insights into disease-specific use and self-perceived benefits of traditional, complementary and integrative medicine in Germany

Publication

Treatment choices : insights into disease-specific use and self-perceived benefits of traditional, complementary and integrative medicine in Germany

von Schoen-Angerer, Tido; Wischnewsky, Manfred; Jeitler, Michael; u. a. (2026): Treatment choices : insights into disease-specific use and self-perceived benefits of traditional, complementary and integrative medicine in Germany, in: BMC complementary medicine and therapies, London: BioMed Central Ltd, Jg. 26, Nr. 1, 282, S. 1–10, doi: 10.1186/s12906-026-05496-y.

Details

Faculty/Chair
Faculty/Professorship
Author
von Schoen-Angerer, Tido
Wischnewsky, Manfred
Jeitler, Michael
Brinkhaus, Benno
Ortiz, Miriam
Kessler, Christian S.
Title of the Journal
BMC complementary medicine and therapies
ISSN
2662-7671
Publisher Information
BioMed Central Ltd : London
Year of publication
2026
Volume
26
Issue
1, 282
Language
English
DOI
Abstract

Background: Previous cross-sectional studies suggest that Traditional, Complementary and Integrative Medicine (TCIM) is used frequently in Germany. We assessed TCIM usage patterns across diferent disease categories in the German population.

Method: In this cross-sectional survey of an online-representative sample of the German population aged 18–75 years, participants were asked about their use and acceptance of TCIM. Participants were also queried about 15 illness categories. Health-related quality of life was assessed using the EQ-5D-5L questionnaire. Data were analyzed descriptively and inferentially.

Results: A total of 4,065 individuals (52% female) responded. 70% had used TCIM at some point in their lives, 32% in the last 12 months, and 18% were current users. Over half (52%) reported a mostly or very positive attitude towards TCIM. The highest rates of TCIM use were reported for acute respiratory illness (55.9%), chronic gastrointestinal illness (51.4%) and acute gastrointestinal illness (49.2%). The illness-specifc, self-reported beneft from TCIM ranged from 61.4 to 86.2% (mean 70.8%) and remained high even among individuals of poorer health-related quality of life. No relation between TCIM use across diferent disease categories and the global research activity in those categories was apparent in the scatter plot.

Conclusions: TCIM is widely used and perceived as benefcial for acute and chronic conditions in Germany. Individuals with poorer health status also reported substantial beneft. Stakeholders in the German healthcare system should critically examine the high level of TCIM use, promote rigorous scientifc evaluation, integrate evidenceinformed TCIM with conventional medicine, and ensure appropriate reimbursement for TCIM through statutory health insurance.

GND Keywords
Deutschland
Alternative Medizin
Keywords
Health care utilization
Delivery of health care
Traditional medicine
Complementary medicine
Integrative medicine
Online-representative
Cross-sectional study
DDC Classification
610 Medicine & health
RVK Classification
MS 6000
MT 10800
Type
Article
URI
Activation date
2026-10-09

Permalink: https://fis.uni-bamberg.de/handle/uniba/117607 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.